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Macrophage fusion: the making of osteoclasts and giant cells
 
Agnès Vignery
 
The fusion of cells is a fundamental biological event that is essential 
for a variety of developmental and homeostatic processes. Fusion is 
required for the formation of multinucleated osteoclasts and giant cells, 
although the mechanisms that govern these processes are poorly understood. 
A new study now reveals an unexpected role for the receptor, dendritic cell–
specific transmembrane protein
 
 
 
(DC-STAMP), in this process. The potential 
mechanism by which DC-STAMP governs fusion and the implications of this 
finding will be discussed.
 
Introduction
 
Macrophages are present in all tissues
and can fuse with other macrophages
to differentiate into multinucleate os-
teoclasts (in bone) or giant cells (in
multiple tissues), which play a central
role in osteoporosis and chronic in-
flammatory diseases, respectively. Multi-
nucleation is an essential step in the
differentiation of osteoclasts, as mono-
nucleated macrophages cannot resorb
bone efficiently, and may also be essen-
tial in the differentiation of giant cells,
which form in tissues in response to
foreign particles. Macrophages might
also fuse with somatic cells to promote
tissue repair and with tumor cells to
trigger metastasis.
On page 345 of this issue, Yagi et
al. (1) show that DC-STAMP is re-
quired for the fusion of preosteoclasts
and macrophages to yield osteoclasts
and giant cells, respectively. DC-
STAMP was first identified in dendritic
cells, which can transdifferentiate and
fuse to yield osteoclasts (2). Thus, clari-
fication of the role of DC-STAMP in
macrophage fusion will be a major step
toward a better understanding of fusion
and will bring together several areas of
research.
 
The mechanics of fusion
 
The first clues about the nature of
membrane fusion came from studies of
viruses. The fusion of viruses with cells,
in particular influenza virus and human
immunodeficiency virus (HIV), pro-
vided strong evidence that fusion is me-
diated both by viral proteins and host
cell surface molecules that function as
viral receptors (3). Thus, a receptor–
ligand interaction mediates the binding
of viruses to the membrane of the host
cell. For example, the HIV surface
ligand gp120 binds to its receptor
(CD4) on T lymphocytes and macro-
phages, and the hemagglutinin protein
of influenza binds to its receptor (sialic
acid) on epithelial cells. Most of the vi-
ral proteins that are responsible for the
binding of the virus to the host cell also
play a role in fusion. For example, the
attachment of HIV to its target cell via
gp120 leads to a conformational change
that exposes the associated fusion pro-
tein gp41 (gp120 and gp41 are derived
from a single protein, gp160, that is
posttranslationally cleaved). These fu-
sion proteins are integral membrane
glycoproteins that exist as oligomers on
the surface of each virion. Most viral fu-
sion proteins contain a stretch of hydro-
phobic amino acids, known as a fusion
peptide, which penetrates host cells like
a sword, destabilizing the lipid bilayer of
the host cell. The fusion protein then
undergoes a conformational change,
forming a hairpin-like 
 
 
 
-helical bundle,
which acts like a spring to propel the vi-
ral membrane close enough to the cell
membrane to trigger fusion.
Another type of fusion occurs be-
tween distinct membranes within a
cell, such as during intracellular traf-
ficking between the endoplasmic retic-
ulum and the Golgi apparatus. Fusion
of an intracellular vesicle with its target
membrane is mediated by a set of con-
served proteins that are collectively re-
ferred to as SNAREs (soluble NSF-
attachment protein [SNAP] receptors).
Many vesicle (v)- and target (t)-
SNAREs have been characterized in
yeast, plants, and animals (4), and
shown to form a bundle of 
 
 
 
-helices
(SNAREpins) that bring opposing
membranes close enough to fuse. The
fusion process between intracellular
membranes occurs in a manner analo-
gous to that between viruses and cells.
A number of putative fusion pro-
teins have recently been identified in
the plasma membrane of various types
of fusing cells from different species,
many of which belong to the immuno-
globulin superfamily of proteins (see
reference 5 for a review). As immuno-
globulin proteins do not contain a fu-
sion peptide or 
 
 
 
-helical spring, these
cannot be the universal tools that me-
diate membrane fusion. As thus far no
two cell types share the same putative
fusion protein, it seems plausible
that alternative mechanisms for fusion
might have evolved for each cell type,
with fusion being cell type–specific and
depending on different proteins in dif-
ferent species (5). Yet, these observa-
tions still support the idea that recep-
tor–ligand interactions are universally
required for fusion.
 
Macrophage fusion: what we know
 
The molecular mechanisms that allow
macrophages to fuse with each other
and, possibly, with somatic and cancer
cells, remain poorly understood. Sev-
eral proteins have been identified that
play a role in macrophage fusion. One
of these proteins, macrophage fusion
receptor (MFR), was identified by
cloning the target of monoclonal anti-
bodies that altered the fusion of rat al-
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veolar macrophages in vitro (6, 7).
MFR and its recently identified ligand
CD47 both belong to the immuno-
globulin superfamily (8). Expression of
CD47 is ubiquitous, whereas that of
MFR is restricted to myeloid cells and
neurons. In addition, the expression of
MFR is induced strongly but tran-
siently in macrophages at the onset
of fusion, whereas the expression of
CD47 remains constant, supporting
the hypothesis that fusion is a regu-
lated event. CD44 is another cell sur-
face receptor similar to MFR whose
expression is induced strongly but
transiently at the onset of fusion in
macrophages. (9). No cell surface li-
gand for CD44 has yet been identi-
fied, perhaps because the extracellular
domain of CD44 is cleaved by mem-
brane type 1–matrix metalloprotein-
ases (10), and may thus be shed from
the plasma membrane of fusing mac-
rophages. Such cleavage would allow
plasma membranes from opposite cells
to interact more closely and, hence,
facilitate fusion. A long and a short
form of MFR have been identified,
leading to a model in which CD47
binds first to the long form of MFR to
secure the attachment of macrophages,
and then switches to the short form of
MFR to bring the plasma membranes
closer to one another. At the same
time, the shedding of the extracellular
domain of CD44 might allow plasma
membranes to get closer (11).
It has been proposed that MFR–
CD47 interactions also play a central
role in cell–cell recognition, which
might be essential for the survival of
the fused macrophages (11). If this is
the case, terminally differentiated mac-
rophages—which are “professional”
phagocytes—might recognize CD47 as
a reciprocal signal of self. This would
allow them to survive “cellocytosis”
(cell–cell internalization), leading to
multinucleation, rather than to the ly-
sosomal degradation of the internalized
cell. Hence, regulating the expression
of MFR might be of central impor-
tance to fusion and the making of a
new multinucleate cell.
MFR belongs to the family of sig-
nal regulatory proteins (SIRPs), which
have intrinsic signaling functions dic-
tated by either a cytoplasmic domain
that contains an immunoreceptor tyro-
sine-based inhibitory motif (ITIM), as
is the case for MFR (also known as
SIRP
 
 
 
), or a transmembrane region
that associates with adaptor molecules
that contain an immunoreceptor acti-
vating motif (ITAM), as is the case for
SIRP
 
 
 
 (12). These ITAM-containing
adaptor molecules (such as DAP12,
CD3
 
 
 
, and the 
 
 
 
 chain of the Fc re-
ceptor [FcR
 
 
 
]), recruit tyrosine ki-
nases (such as Syk or ZAP70) that
trigger the activation of downstream
signaling events. ITIMs recruit tyro-
sine phosphatases, such as Src homol-
ogy 2 domain tyrosine phosphatase
(SHP) 1 and SHP-2, that negatively
regulate ITAM signaling.
Recently, it was reported that mice
that lack DAP12 and/or FcR
 
 
 
 develop
mild osteopetrosis, a disease associated
with a defect in the differentiation or
activation of osteoclasts, which leads to
the thickening of bones (13, 14). It was
concluded in that study that, upon acti-
vation of surface receptors, the ITAM
domains of DAP12 and FcR
 
 
 
 become
phosphorylated and initiate activating
downstream signals. Conversely, mice
with a mutation in SHP-1 develop se-
vere osteoporosis (loss of bone), which
is associated with an increase in the dif-
ferentiation and activation of osteo-
clasts (15, 16). Given the link between
fusion and osteoclast differentiation, it
is possible that the intracellular signal-
ing pathways downstream of MFR and
SIRP
 
 
 
, involving ITAM–ITIM cross
Figure 1. Potential mechanism of fusion of preosteoclasts and of macrophages. Osteoclast 
precursor cells respond to the osteoclast differentiation factor RANKL, which induces the expression 
of DC-STAMP. The DC-STAMP–expressing osteoclast becomes the master fusing cell, which can 
fuse with a DC-STAMP–negative follower cell. The ligand for DC-STAMP may be membrane bound 
or soluble; a soluble ligand might be released by either of the fusion partners. DC-STAMP ligation 
may trigger fusion of the two cells directly or may trigger the expression of as yet unknown 
membrane-bound molecules (‘X’) that mediate fusion. A similar scenario may occur during the 
formation of giant cells in which macrophages respond to interleukin-4 by inducing the expression 
of DC-STAMP, which then facilitates fusion.
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talk, might be functionally linked to
modulate fusion.
 
DC-STAMP: a new kid on the block
 
DC-STAMP was identified from a
screening of human monocyte cDNA
libraries (17) as a putative seven-trans-
membrane–spanning receptor with no
homology to any other known protein
or multimembrane-spanning receptor.
DC-STAMP is expressed both in im-
mature and mature dendritic cells
(DCs), and its mRNA levels fall upon
activation of DCs with CD40 ligand
(CD40L). DC-STAMP is overex-
pressed in giant cell tumors together
with receptor activator of NF-
 
 
 
B
ligand (RANKL), a protein required
for the development of osteoclasts (18).
In a recent study, Kukita et al. showed,
using small interfering RNAs and spe-
cific antibodies, that DC-STAMP is es-
sential for osteoclastogenesis in mice
(2). They reported that overexpression
of DC-STAMP enhanced osteoclasto-
genesis and induced the expression of a
marker of osteoclasts, tartrate-resistant
acid phosphatase. In this issue, Yagi et
al. (1) used gene targeting to demon-
strate that DC-STAMP is also essential
for the fusion of osteoclast precursor
cells and macrophages. Mice that lack
DC-STAMP had mononucleated os-
teoclasts and developed mild osteo-
petrosis. In contrast to the study by
Kukita et al. (2), the mild osteopetrosis
that developed in the DC-STAMP–
deficient mice was attributed by Yagi
et al. to the defect in the fusion of os-
teoclasts, rather than a defect in osteo-
clast differentiation, which occurred
normally. Hence, osteoclasts from defi-
cient mice were unable to resorb bone
as efficiently as multinucleated osteo-
clasts. This phenomenon was observed
despite the expression of 
 
MFR
 
, 
 
CD47,
 
and 
 
CD44
 
—components of the puta-
tive fusion machinery—as well as
 
E-cadherin
 
 and 
 
meltrin-
 
 
 
, which have
been suggested to participate in multi-
nucleation (19, 20). It is important to
stress here that the level of 
 
MFR
 
 and
 
CD44
 
 transcripts is not elevated in
macrophages during fusion. Rather, ex-
pression of MFR and CD44 protein is
induced transiently at the onset of fu-
sion, possibly by a mechanism that op-
erates posttranscriptionally (7, 9). Thus,
definition of the kinetics of expression
of MFR, CD47, and CD44 protein in
the mutant mice might provide clues to
their various roles in fusion. It is possi-
ble that DC-STAMP promotes fusion
via the transient induction of MFR and
CD44 protein expression, or the in-
duction of an as yet unknown protein.
Another important finding reported
by Yagi et al. (1) is that fusion is not re-
quired for bone resorption, as DC-
STAMP–deficient macrophages differ-
entiated into osteoclasts but remained
mononucleated. Although it has been
shown previously that mononucleated
osteoclasts resorb bone poorly, mice de-
ficient in DC-STAMP provide a clear
confirmation of this phenomenon.
Their findings demonstrate that fusion is
not required for the differentiation of
osteoclasts and giant cells and that both
cell types require the expression of DC-
STAMP to become multinucleated.
The most elegant experiment per-
formed by Yagi et al. involved a cofu-
sion assay, in which bone marrow mac-
rophages that originated from mutant
mice that expressed green fluorescent
protein (GFP) in lieu of DC-STAMP
were mixed with those from wild-type
mice. In this assay, multinucleate bone
marrow cells expressed GFP, suggest-
ing that fusion occurred between a
“founder” fusing cell that expressed
DC-STAMP and a “follower” cell that
did not. This observation confirms the
hypothesis that one macrophage must
take the lead in “cellocytosing” another
one (11). Once fusion of two cells has
been initiated and completed, the two
cells form a binucleate cell which then
becomes the “leader” or “master” fuser
and can fuse with other mono- or
multinucleated cells. The results re-
ported by Yagi et al. suggest that ex-
pression of DC-STAMP is not re-
quired in every fusing cell, but rather
that DC-STAMP must be expressed by
the master fusing cell (Fig. 1). It is
now  important to identify the ligand
for DC-STAMP and to determine
whether its expression is required by
both members of a pair of fusing cells.
Also, although Yagi et al. conclude that
the ligand for DC-STAMP is a surface
protein expressed by macrophages, one
cannot exclude the possibility that it is
a soluble protein that is released by
macrophages in a constitutive or regu-
lated manner. Such a ligand might be
released by the master cell, the follower
cell, or both. An intriguing possible
ligand is the chemokine CCL2 (mono-
cyte chemoattractant protein 1), which
has recently been shown to participate
in the formation of foreign body giant
cells and in osteoclast fusion (21, 22).
This possibility is supported by the
structural similarity between DC-STAMP
and chemokine receptors, which are
also seven-transmembrane–spanning pro-
teins. This also suggests the possibility
that DC-STAMP may function as a
fusion co-receptor on macrophages.
Chemokine receptors on macrophages
and T cells are known to play critical
roles as coreceptors for viral entry dur-
ing infection (23). For HIV, the che-
mokine receptors CXCR4 and CCR5
are the principal coreceptors for T cell–
tropic and macrophage–tropic 1 iso-
lates of HIV, respectively. Yagi et al.
argue that DC-STAMP is not a recep-
tor for a soluble chemokine, as DC-
STAMP–deficient macrophages plated
at high density still failed to fuse.
Nonetheless, it cannot be excluded that
a soluble factor, released by macro-
phages, might activate DC-STAMP to
promote fusion.
It will also be important to de-
termine whether expression of DC-
STAMP is required for fusion of mac-
rophages with somatic and cancer cells
(11). If tissue macrophages express DC-
STAMP, this might explain why these
cells can fuse and express osteoclast
markers independently of the essential
osteoclast growth factor RANKL (24).
The finding that DC-STAMP is re-
quired for the fusion of both osteoclasts
and giant cells leads us to question the
long-standing dogma that osteoclasts
and giant cells are different entities and
are unlikely to share the same fusion
machinery, even though both cell types
originate from the fusion of mononu-
cleate precursor cells that belong to the
monocyte–macrophage lineage, both
resorb the substrate onto which they
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adhere (bone for osteoclasts; foreign
bodies for giant cells), and no molecule
has been identified that is expressed in
one cell type and not in the other.
Hence, the primary differences be-
tween these two types of cell are likely
to be found in the nature of their tar-
gets, and the nature of their microenvi-
ronments. Establishment of a role for
DC-STAMP in macrophage fusion is
extremely important and suggests that
osteoclasts and giant cells use similar
machinery for fusion (24, 11).
 
Concluding thoughts
 
The elegant and conclusive work of
Yagi et al. both breaks down barriers
and raises new questions. It remains to
be determined where DC-STAMP is
localized during macrophage fusion—
possibly clustering in specific domains
within the plasma membrane or in the
endoplasmic reticulum (25). It will also
be critical to define the signals that
both regulate the expression of DC-
STAMP and act downstream of DC-
STAMP. We know that its expression
is induced by both RANKL and inter-
leukin-4, which paradoxically stimulate
and inhibit fusion, respectively. We
also know that the gene for DC-
STAMP contains several putative bind-
ing sites for NF-
 
 
 
B and octamer factors
(26), but there are undoubtedly many
regulatory mechanisms that remain un-
defined. It is also unclear whether DC-
STAMP associates with MFR, CD47,
and/or CD44, as proposed for HIV in-
teraction with chemokine receptors
during fusion (23). Hence, a careful
dissection of the signaling events initi-
ated by DC-STAMP ligation will lead
to a clearer understanding of how fu-
sion is initiated.
 
The author thanks Dr. Ann Körner for her careful 
editing of this manuscript.
 
REFERENCES
 
1. Yagi, M., T. Miyamoto, Y. Sawatani, K.
Iwamoto, N. Hosogane, N. Fujita, K.
Morita, K. Ninomiya, T. Suzuki, K. Miya-
moto, et al. 2005. DC-STAMP is essential
for cell-cell fusion in osteoclasts and foreign
body giant cells. 
 
J. Exp. Med.
 
 203:345–
351.
2. Kukita, T., N. Wada, A. Kukita, T. Kaki-
moto, F. Sandra, K. Toh, K. Nagata, T.
Iijima, M. Horiuchi, H. Matsusaki, et al.
2004. RANKL-induced DC-STAMP is es-
sential for osteoclastogenesis. 
 
J. Exp. Med.
 
200:941–946.
3. Earp, L.J., S.E. Delos, H.E. Park, and J.M.
White. 2005. The many mechanisms of viral
membrane fusion proteins. 
 
Curr. Top. Micro-
biol. Immunol.
 
 285:25–66 (Review.).
4. Weber, T., B.V. Zemelman, J.A. McNew,
B. Westermann, M. Gmachl, F. Parlati,
T.H. Sollner, and J.E. Rothman. 1998.
SNAREpins: minimal machinery for mem-
brane fusion. 
 
Cell.
 
 92:759–772.
5. Chen, E.H., and E.N. Olson. 2005. Unveil-
ing the mechanisms of cell-cell fusion. Sci-
ence 308:369-373. Review.
6. Saginario, C., H.-Y. Qian, and A. Vignery.
1995. Identification of an inducible surface
molecule specific to fusing macrophages.
 
Proc. Natl. Acad. Sci. USA.
 
 92:12210–12214.
7. Saginario, C., H. Sterling, C. Beckers, R.-J.
Kobayashi, M. Solimena, E. Ullu, and A.
Vignery. 1998. MFR, a putative receptor
mediating the fusion of macrophages. 
 
Mol.
Cell. Biol.
 
 18:6213–6223.
8. Han, X., H. Sterling, V. Saginario, Y.-M.
Chen, E. Brown, W.A. Frazier, F.P. Lind-
berg, and A. Vignery. 2000. CD47, a ligand
for MFR, participates in macrophage mul-
tinucleation. 
 
J. Biol. Chem.
 
 275:37984–
37992.
9. Sterling, H., C. Saginario, and A. Vignery.
1998. CD44 occupancy prevents the fusion
of macrophages. 
 
J. Cell Biol.
 
 143:837–847.
10. Kajita, M., Y. Itoh, T. Chiba, H. Mori, A.
Okada, H. Kinoh, and M. Seiki. 2001.
Membrane-type 1 matrix metalloproteinase
cleaves CD44 and promotes cell migration.
 
J. Cell Biol.
 
 153:893–904.
11. Vignery, A. 2005. Macrophage fusion: are
somatic and cancer cells possible partners?
 
Trends Cell Biol.
 
 15:188–193.
12. Koga, T., M. Inui, K. Inoue, S. Kim, A.
Suematsu, E. Kobayashi, T. Iwata, H.
Ohnishi, T. Matozaki, T. Kodama, et al.
2004. Costimulatory signals mediated by the
ITAM motif cooperate with RANKL for
bone homeostasis. 
 
Nature.
 
 428:758–763.
13. Mocsai, A., M.B. Humphrey, J.A. Van Zif-
fle, Y. Hu, A. Burghardt, S.C. Spusta, S.
Majumdar, L.L. Lanier, C.A. Lowell, and
M.C. Nakamura. 2004. The immunomodu-
latory adapter proteins DAP12 and Fc re-
ceptor gamma-chain (FcRgamma) regulate
development of functional osteoclasts through
the Syk tyrosine kinase. 
 
Proc. Natl. Acad. Sci.
USA.
 
 101:6158–6163.
14. Dietrich, J., M. Cella, M. Seiffert, H.J. Buhr-
ing, and M. Colonna. 2000. Cutting edge:
signal-regulatory protein beta 1 is a DAP12-
associated activating receptor expressed in
myeloid cells. 
 
J. Immunol.
 
 164:9–12.
15. Umeda, S., W.G. Beamer, K. Takagi, M.
Naito, S. Hayashi, H. Yonemitsu, T. Yi,
and L.D. Shultz. 1999. Deficiency of SHP-1
protein-tyrosine phosphatase activity results
in heightened osteoclast function and de-
creased bone density. 
 
Am. J. Pathol.
 
 155:
223–233.
16. Aoki, K., E. Didomenico, N.A. Sims, K.
Mukhopadhyay, L. Neff, A. Houghton, M.
Amling, J.B. Levy, W.C. Horne, and R.
Baron. 1999. The tyrosine phosphatase
SHP-1 is a negative regulator of osteoclasto-
genesis and osteoclast resorbing activity: in-
creased resorption and osteopenia in me(v)/
me(v) mutant mice. 
 
Bone.
 
 25:261–267.
17. Hartgers, F.C., J.L. Vissers, M.W. Looman,
C. van Zoelen, C. Huffine, C.G. Figdor,
and G.J. Adema. 2000. DC-STAMP, a
novel multimembrane-spanning molecule
preferentially expressed by dendritic cells.
 
Eur. J. Immunol.
 
 30:3585–3590.
18. Skubitz, K.M., E.Y. Cheng, D.R. Clohisy,
R.C. Thompson, and A.P. Skubitz. 2004.
Gene expression in giant-cell tumors. 
 
J. Lab.
Clin. Med.
 
 144:193–200.
19. Mbalaviele, G., H. Chen, B.F. Boyce, G.R.
Mundy, and T. Yoneda. 1995. The role of
cadherin in the generation of multinucleated
osteoclasts from mononuclear precursors in
murine marrow. 
 
J. Clin. Invest.
 
 95:2757–
2765.
20. Abe, E., H. Mocharla, T. Yamate, Y. Tagu-
chi, and S.C. Manolagas. 1999. Meltrin-
alpha, a fusion protein involved in multinu-
cleated giant cell and osteoclast formation.
 
Calcif. Tissue Int.
 
 64:508–515.
21. Kyriakides, T.R., M.J. Foster, G.E. Keeney,
A. Tsai, C.M. Giachelli, I. Clark-Lewis, J.
Rollins, and P. Bornstein. 2004. The CC
chemokine ligand, CCL2/MCP1, partici-
pates in macrophage fusion and foreign
body giant cell formation. 
 
Am. J. Pathol.
 
165:2157–2166.
22. Kim, M.S., C.J. Day, and N.A. Morrison.
2005. MCP-1 is induced by receptor activa-
tor of nuclear factor-{kappa}B ligand, pro-
motes human osteoclast fusion, and rescues
granulocyte macrophage colony-stimulat-
ing factor suppression of osteoclast forma-
tion. 
 
J. Biol. Chem.
 
 280:16163–16169.
23. Berger, E.A., P.M. Murphy, and J.M. Far-
ber. 1999. Chemokine receptors as HIV-1
coreceptors: roles in viral entry, tropism and
disease. 
 
Annu. Rev. Immunol.
 
 17:657–700.
24. Vignery, A. 2000. Osteoclasts and giant
cells: macrophage-macrophage fusion mech-
anism. 
 
Int. J. Exp. Pathol.
 
 81:291–304.
25. Eleveld-Trancikova, D., V. Triantis, V.
Moulin, M.W. Looman, M. Wijers, J.A.
Fransen, A.A. Lemckert, M.J. Havenga,
C.G. Figdor, R.A. Janssen, and G.J. Adema.
2005. The dendritic cell-derived protein
DC-STAMP is highly conserved and local-
izes to the endoplasmic reticulum. 
 
J. Leukoc.
Biol.
 
 77:337–343.
26. Hartgers, F.C., M.W. Looman, B. van der
Woning, G.F. Merkx, C.G. Figdor, and
G.J. Adema. 2001. Genomic organization,
chromosomal localization, and 5
 
 
 
 upstream
region of the human DC-STAMP gene. 
 
Im-
munogenetics.
 
 53:145–149.
 
20051123  Page 340  Wednesday, July 20, 2005  9:34 PM